4:11 PM ET
8-K
Leadership Change
Travere Therapeutics Leadership Change
Travere Therapeutics announced that Eric Dube, Ph.D., will step down as President, CEO, and Board member effective December 1, 2026. Bradley L. Campbell, former CEO of Amicus Therapeutics, has been appointed as his successor. Dr. Dube will remain as an Executive Advisor through February 15, 2027, to facilitate a smooth leadership transition.
- Counterparty
- Bradley L. Campbell